Form 4 for RRX REGAL REXNORD CORP
Accepted 2022-08-10 00:00:00 ET · period of report 2022-08-08 · accession 0000082811-22-000156 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-08-10 | 2022-08-08 | RRX | Kunze John C | Segment Pres* | M - OptEx | $127.32 | +1,720 | 8,640 | +25% | +$219.0K |
| D | 2022-08-10 | 2022-08-08 | RRX | Kunze John C | Segment Pres* | S - Sale+OE | $139.42 | -1 | 6,999 | -0.0% | -$139.42 |
| D | 2022-08-10 | 2022-08-08 | RRX | Kunze John C | Segment Pres* | F - Tax | $139.15 | -1,640 | 7,000 | -19% | -$228.2K |
| DM | 2022-08-10 | 2022-08-08 | RRX | Kunze John C | Segment Pres* | M - OptEx | $0.00 | -1,720 | 2,934 | -37% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-08 | M | A | 31 | $74.04 | 8,528.42 | D | — | — | |
| 2 | Common | Common Stock | 2022-08-08 | S | D | 1 | $139.42 | 6,999.42 | D | — | — | |
| 3 | Common | Common Stock | 2022-08-08 | M | A | 31 | $76.99 | 6,951.42 | D | — | — | |
| 4 | Common | Common Stock | 2022-08-08 | M | A | 1,511 | $133.77 | 8,462.42 | D | — | — | |
| 5 | Common | Common Stock | 2022-08-08 | M | A | 35 | $78.05 | 8,497.42 | D | — | — | |
| 6 | Common | Common Stock | 2022-08-08 | M | A | 112 | $84.39 | 8,640.42 | D | — | — | |
| 7 | Common | Common Stock | 2022-08-08 | F | D | 1,640 | $139.15 | 7,000.42 | D | — | — | |
| 8 | Derivative | Stock Appreciation Rights | 2022-08-08 | M | D | 31 | $0.00 | 681 | D | $74.04 · 2020-05-09 to 2028-05-09 | 31 Common Stock | (F2) Granted as stock-settled SARs under the 2018 Equity Incentive Plan. The SARs vest and become exercisable 40% on the second anniversary, 60% on the third anniversary, 80% on the fourth anniversary and 100% on the fifth anniversary of the date of the grant. |
| 9 | Derivative | Stock Appreciation Rights | 2022-08-08 | M | D | 31 | $0.00 | 0 | D | $76.99 · 2019-05-10 to 2027-05-10 | 31 Common Stock | (F1) Granted as stock-settled Stock Appreciation Rights ("SARs") under the 2013 Equity Incentive Plan. The SARs vest and become exercisable 40% on the second anniversary, 60% on the third anniversary, 80% on the fourth anniversary and 100% on the fifth anniversary of the date of the grant. |
| 10 | Derivative | Stock Appreciation Rights | 2022-08-08 | M | D | 112 | $0.00 | 2,443 | D | $84.39 · 2021-02-18 to 2030-02-18 | 112 Common Stock | (F3) Granted as stock-settled SARs under the 2018 Equity Incentive Plan. The SARs vest and become exercisable 34% on the first anniversary, 67% on the second anniversary and 100% on the third anniversary of the date of the grant. |
| 11 | Derivative | Stock Appreciation Rights | 2022-08-08 | M | D | 35 | $0.00 | 1,510 | D | $78.05 · 2021-05-08 to 2029-05-08 | 35 Common Stock | (F2) Granted as stock-settled SARs under the 2018 Equity Incentive Plan. The SARs vest and become exercisable 40% on the second anniversary, 60% on the third anniversary, 80% on the fourth anniversary and 100% on the fifth anniversary of the date of the grant. |
| 12 | Derivative | Stock Appreciation Rights | 2022-08-08 | M | D | 1,511 | $0.00 | 2,934 | D | $133.77 · 2022-02-23 to 2031-02-23 | 1,511 Common Stock | (F3) Granted as stock-settled SARs under the 2018 Equity Incentive Plan. The SARs vest and become exercisable 34% on the first anniversary, 67% on the second anniversary and 100% on the third anniversary of the date of the grant. |